AB
Antlia Bioscience, Inc.
SEC filingBiotechnology · Encinitas, CA
Amount raised$6Msold at filing
Total offering$20M$14M still open
Investors in the raise3count reported to the SEC
FiledJun 5, 2026first sale May 22, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ankit MahadeviaExecutive Officer, Director
Ben AuspitzDirector
Martin Garcia TaylorDirector
Carlos Garcia EcheverriaDirector
Nihal Garcia SinhaDirector
Brian Laurence JohnsonExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.